Latest Form 4 insider transactions

Robyn R. Werner, a Director of Eastgroup Properties Inc, reported multiple transactions in common stock on October 8, 2026.

D Keith Grossman, a Director of MiniMed Group, Inc., received 11,795 shares of common stock on October 9, 2026.

Margaret Tooth, CEO and a Director of Trupanion, Inc., sold 1,000 shares of common stock on October 9, 2026 for $25.84 per share.

David J. Endicott, a Director of MiniMed Group, Inc., received 11,795 shares of common stock on October 9, 2026.

Glenn A Eisenberg, a Director of MiniMed Group, Inc., received 11,795 shares of common stock on October 9, 2026.

David J. Lee, See Remarks and a Director of WEBTOON Entertainment Inc., reported a transaction in 9,485 shares of common stock on October 12, 2026.

Karalyn Yearout, EVP CHIEF TALENT OFFICER of Williams Sonoma Inc, sold 522 shares of common stock on October 9, 2026 for $239.36 per share.

Ned N Fleming Iii, a Director and 10% owner of Construction Partners, Inc., reported multiple transactions in common stock on October 8, 2026.

David A Duffield, a 10% owner of Workday, Inc., sold 99,835 shares of common stock on October 9, 2026.

Chris Siu, CFO of Aehr Test Systems, reported a transaction in 987 shares of common stock on October 12, 2026.

Alistair N Sporck, VP Contactor Business Unit of Aehr Test Systems, reported a transaction in 295 shares of common stock on October 12, 2026.

Mark James King, Exec Chairman & Interim CEO and a Director of Jack In The Box Inc, sold 7,013 shares of common stock on October 13, 2026 for $12.18 per share.

Andrew Leaver, Chief Executive Officer of Arqit Quantum Inc., reported multiple transactions in common stock on October 12, 2026.

Catherine Kiernan Hogan, Chief Operating Officer of Accenture plc, sold 700 shares of common stock on October 12, 2026.

Opaleye Management Inc. reported changes in beneficial ownership of Grace Therapeutics, Inc. common stock on October 8, 2026.

Joseph Michael Lubin, a Director of SharpLink Gaming, Inc., sold 5,676,952 shares of common stock on October 8, 2026 for $8.39 per share.

David A Henry, Chief Financial Officer of Myomo, Inc., reported multiple transactions in common stock on October 9, 2026.

Meghan Frank, Chief Financial Officer of lululemon athletica inc., received 42,328 shares of common stock on October 9, 2026.

Thomas Marks, EVP, Business Development of Evi Industries, Inc., reported a transaction in 831 shares of common stock on October 9, 2026.

Stephen Paul Patak, Chief Revenue Officer of BurTech Acquisition Corp., reported multiple transactions in common stock on October 12, 2026.

Henry M Nahmad, Chairman, CEO & President, a Director and 10% owner of Evi Industries, Inc., reported a transaction in 8,198 shares of common stock on October 9, 2026.

Paul R Gudonis, Chief Executive Officer and a Director of Myomo, Inc., received 8,363 shares of common stock on October 9, 2026.

Edward J Rapp, a Director of Xos, Inc., received 1,814 shares of common stock on October 10, 2026.

Ryan A King, Co-Founder and a Director of Chime Financial, Inc., sold 50,300 shares of common stock on October 9, 2026.

Robert Lazar, Chief Financial Officer of Evi Industries, Inc., reported multiple transactions in common stock on October 9, 2026.

Quang X Pham, Chairman and CEO, a Director and 10% owner of Cadrenal Therapeutics, Inc., received 200,000 shares of common stock on October 9, 2026.

Lee Scott Golden, a Director of Cadrenal Therapeutics, Inc., received 75,000 shares of common stock on October 9, 2026.

John Raymond Murphy, a Director of Cadrenal Therapeutics, Inc., received 75,000 shares of common stock on October 9, 2026.

Jeffrey Scott Cole, Chief Operating Officer of Cadrenal Therapeutics, Inc., received 150,000 shares of common stock on October 9, 2026.

Chantal Wessels, a Director of VenHub Global, Inc., received 25,000 shares of common stock on October 9, 2026.